Regeneron Pharmaceuticals
The Digital Health Technologies (DHT) Manager oversees the implementation of digital tools and technologies, such as eCOA and wearables, throughout the clinical research lifecycle from design to close-out. This role collaborates with study teams to manage vendor performance, enforce system standards, and ensure data collection compliance with ICH/GCP regulations. Responsibilities include driving strategy for digital modalities, providing stakeholder training, and managing project timelines for both internal studies and outsourced research organizations.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
11% above the average for this role
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Sr. Manager - Project Manager, Digital Health Technology (DHT) & eCOA
Kardigan
Associate eCOA Manager
Worldwide Clinical Trials
Digital Health Operations Lead
IQVIA
eCOA Manager, Clinical Assessment Technologies - UK - Remote
Worldwide Clinical Trials
Senior Digital Health Technologies (DHT) Specialist
Parexel
Project Manager
Bioclinica